Stock Research

Novartis beat market expectations for second-quarter core operating profit on Tuesday. Lower-than-expected costs helped the Swiss drugmaker offset a sharp decline in sales of its top-selling heart failure drug Entresto. The company reported quarterly group operating income of $5.94 billion, adjusted for special items. That was above average analyst expectations of about $5.31 billion, according… Continue reading Novartis Q2 surpasses estimates despite 50% Entresto sales drop

Japanese stocks rose on Tuesday as investors returned from a long weekend and bought into last week’s steep technology-led sell-off, though the rebound stopped short of signalling a durable turn in sentiment. The Nikkei 225 gained 1.25% to 64,945.96 in early trade, recovering only part of its 6.4% weekly slide, the sharpest in more than… Continue reading Nikkei 225 rebounds sharply as AI earnings become market’s next big test

Trump’s latest trade offensive has placed North America’s best-known manufacturers and consumer brands under scrutiny, with integrated US-Canadian supply chains facing a cost shock. The White House imposed additional 50% duties on specified Canadian imports under three proclamations responding to disputes over motor vehicles, alcoholic beverages and dairy. The covered tariff lines include products such… Continue reading Trump’s Canada tariffs: 4 stocks facing the biggest cross-border shock

As market volatility and shifting economic conditions test investor resolve, high-quality dividend payers remain a cornerstone for long-term growth and income. Josh Brown – the chief executive of Ritholtz Wealth Management – recently highlighted a trio of industry-leading insurance firms as top dividend stocks to own in 2026: The Travelers Companies, Chubb, and Aflac. Known… Continue reading Josh Brown names top dividend stocks to own in 2026

US stocks ended mixed on Monday as investors balanced hopes of easing in the US-Iran conflict against uncertainty ahead of a crucial week of corporate earnings. While semiconductor stocks rebounded from last week’s selloff, broader market sentiment remained cautious. The Dow Jones Industrial Average fell 297 points, or 0.57%, to close at 51,848.96. The S&P… Continue reading Dow falls 290 points as Nasdaq steadies on chip rebound, earnings focus

UK stocks closed lower on Monday as investors weighed continued geopolitical tensions in the Middle East alongside the appointment of Andy Burnham as the United Kingdom’s new prime minister and the formation of his cabinet. The FTSE 100 declined 0.7%, marking its biggest one-day fall in about two weeks. The FTSE 250 slipped 0.3%, while… Continue reading FTSE closes lower as Andy Burnham unveils cabinet

Alphabet (GOOGL) shares climbed about 3% on Monday after a report said Google is developing a new AI server chip designed specifically to run its Gemini models more efficiently. According to The Information, the chip, internally codenamed “Frozen v2,” would permanently embed parts of Gemini’s architecture into the silicon. The design is intended to reduce… Continue reading Why is Alphabet stock gaining today?

Nvidia (NVDA) stock traded modestly higher on Monday, but investor attention is increasingly shifting toward the upcoming earnings season, where major technology companies are expected to provide fresh updates on artificial intelligence spending. Shares of the AI chipmaker rose 0.93% to $204.69 on Monday, although the gain trailed the 1.8% advance in the PHLX Semiconductor… Continue reading Nvidia stock: what does it need to get its mojo back

Oracle ORCL shares fell more than 3.5% on Monday after CLSA initiated coverage with a Hold rating, warning that the software company could require as much as $500 billion in capital to support its artificial intelligence cloud expansion through 2030. The brokerage said Oracle’s internal cash generation would be sufficient to fund only around one-fifth… Continue reading Oracle stock falls 3% to 52-week low: what’s ailing the company?